Journal
NUTRIENTS
Volume 12, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/nu12041166
Keywords
nonalcoholic steatohepatitis (NASH); lemon balm extract (LBE); rosmarinic acid (RA); AMP-activated protein kinase (AMPK); antioxidants; anti-inflammation
Categories
Funding
- National Research Council of Science and Technology (NST) - Korean Government (Ministry of Science and ICT) [CRC-15-01-KIST]
- Korea Institute of Science and Technology [2Z06110]
- National Research Foundation of Korea [2Z06110] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Ask authors/readers for more resources
Nonalcoholic fatty liver disease (NAFLD) ranges in severity from hepatic steatosis to cirrhosis. Lemon balm and its major constituent, rosmarinic acid (RA), effectively improve the liver injury and obesity; however, their therapeutic effects on nonalcoholic steatohepatitis (NASH) are unknown. In this study, we investigated the effects of RA and a lemon balm extract (LBE) on NAFLD and liver fibrosis and elucidated their mechanisms. Palmitic acid (PA)-exposed HepG2 cells and db/db mice fed a methionine- and choline-deficient (MCD) diet were utilized to exhibit symptoms of human NASH. LBE and RA treatments alleviated the oxidative stress by increasing antioxidant enzymes and modulated lipid metabolism-related gene expression by the activation of adenosine monophosphate-activated protein kinase (AMPK) in vitro and in vivo. LBE and RA treatments inhibited the expression of genes involved in hepatic fibrosis and inflammation in vitro and in vivo. Together, LBE and RA could improve liver damage by non-alcoholic lipid accumulation and may be promising medications to treat NASH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available